Mark Milton Edwards, MBA TEVA Pharmaceuticals

Mark is responsible for the Health Solutions within Digital Health at TEVA Pharmaceuticals.

He has been with TEVA over ten years and prior to that sixteen with AstraZeneca.

Mark has held various positions including R&D Project Leader, VP Sales & Marketing, Strategic Planning & Business Development, and Global Brand Lead.

Mark graduated in Aeronautical Sciences and completed his MBA at Durham University, UK. During his career, he has led technology & especially inhaler development teams through engineering, CMC characterisation, clinical evidence generation, registration within US, EU and International Markets, and ultimately to successful global launch.

Mark has numerous patents granted and pending in electronic communications, sports technologies, inhaled pharmaceutical development, and respiratory physiological function & predictive AI. Mark is the inventor of Digihaler®, the first FDA approved digital inhaler with built-in sensors.